Results

Total Results: 1,583 records

Showing results for "liver".
Users also searched for: hepatitis c

421. Identification, Classification, and Frequency of Medical Errors in Outpatient Diabetes Care (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/OConnor.pdf
     November 29, 2004 - lipid disorders (LDL > 100 mg/dl, or triglycerides > 200 mg/dl after a minimum 12-hour fast), abnormal liver … patients with relative contraindications to their use—like renal insufficiency, congestive heart failure, liver … ALT/AST=liver alanine and aspartate transaminase enzyme measurements that reflect liver status.

422. Benefits of Subglottic Secretion Drainage Endotracheal Tubes: Facilitator Guide | Agency for Healthcare Research and Quality
     www.ahrq.gov/hai/tools/mvp/modules/technical/subglottic-fac-guide.html
     January 01, 2017 - ICU, and patients involved in high-risk surgical procedures such as thoracic aortic aneurysm repair, liver

423. Toxic Tachycardia | PSNet
     psnet.ahrq.gov/web-mm/toxic-tachycardia
     March 01, 2005 - Liver function test abnormalities are not uncommon ( 4 ), and diffuse abdominal pain and hepatosplenomegaly … Abnormalities of liver function tests in thyrotoxicosis. Mil Med. 1978;143:548-551.

424. Nrd 2014 Maskedstats Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Severity.PDF
     January 01, 2014 - comorbidity measure: Hypothyroidism 14,894,613 0 0.00 1.00 0.10 0.31 CM_LIVER : AHRQ comorbidity measure: Liver … Friday, October 28, 2016 4 Frequency Distribution for APRDRG APRDRG Frequency Percent of Total 1: Liver … hemorrhage 105,346 0.71% 254: Other digestive system diagnoses 132,890 0.89% 260: Major pancreas, liver … disorders 46,825 0.31% 280: Alcoholic liver disease 30,408 0.20% 281: Malignancy of hepatobiliary … Frequency Distribution for APRDRG APRDRG Frequency Percent of Total 283: Other disorders of the liver

425. Maskedstats Nrd 2015Q1Q3 Severity (pdf file)
     hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q1Q3_Severity.PDF
     October 31, 2017 - comorbidity measure: Hypothyroidism 12,927,179 0 0.00 1.00 0.11 0.31 CM_LIVER : AHRQ comorbidity measure: Liver … Tuesday, October 31, 2017 4 Frequency Distribution for APRDRG APRDRG Frequency Percent of Total 1: Liver … hemorrhage 92,336 0.71% 254: Other digestive system diagnoses 116,584 0.90% 260: Major pancreas, liver … disorders 41,378 0.32% 280: Alcoholic liver disease 26,398 0.20% 281: Malignancy of hepatobiliary … Frequency Distribution for APRDRG APRDRG Frequency Percent of Total 283: Other disorders of the liver

426. Maskedstats Nis 2019 Core Weighted V2 (pdf file)
     hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2019_Core_Weighted_V2.PDF
     January 01, 2019 - TRANSPLANT W MCC OR INTESTINAL TRANSPLANT 5,835 0.02% 6: LIVER TRANSPLANT W/O MCC 2,250 0.01% 7: LUNG … & SHUNT PROCEDURES W CC 17,070 0.05% 407: PANCREAS, LIVER & SHUNT PROCEDURES W/O CC/MCC 7,100 0.02% … EXCEPT MALIG,CIRR,ALC HEPA W MCC 46,255 0.13% 442: DISORDERS OF LIVER EXCEPT MALIG, CIRR, ALC HEPA … W CC 14,830 0.04% 442: DISORDERS OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W CC 48,565 0.14% 443: DISORDERS … OF LIVER EXCEPT MALIG, CIRR, ALC HEPA W/O CC/MCC 4,005 0.01% 443: DISORDERS OF LIVER EXCEPT MALIG,CIRR

427. Kid 2019 Maskedstats Core Weighted V2 (pdf file)
     hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_Weighted_V2.PDF
     January 01, 2019 - O.R. 3,760 0.06% 4: TRACH W MV >96 HRS OR PDX EXC FACE, MOUTH & NECK W/O MAJ O.R. 1,663 0.03% 5: LIVER … TRANSPLANT W MCC OR INTESTINAL TRANSPLANT 439 0.01% 6: LIVER TRANSPLANT W/O MCC 139 0.00% 7: LUNG … , LIVER & SHUNT PROCEDURES W/O CC/MCC 201 0.00% 408: BILIARY TRACT PROC EXCEPT ONLY CHOLECYST W OR W … 947 0.02% 442: DISORDERS OF LIVER EXCEPT MALIG, CIRR, ALC HEPA W CC 364 0.01% 442: DISORDERS OF LIVER … EXCEPT MALIG,CIRR,ALC HEPA W CC 1,256 0.02% 443: DISORDERS OF LIVER EXCEPT MALIG, CIRR, ALC HEPA W/

428. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
     April 06, 2010 -  Hypoglycemia  Liver injury  Congestive heart failure  Severe lactic acidosis  Cancer  Severe … Retinopathy • Nephropathy • Neuropathy The outcomes for Key Question 3 are: • Hypoglycemia • Liver … □ For Key Question 3, we included the following outcomes: hypoglycemia, liver injury, congestive … □ We included crossover studies for the outcomes of hypoglycemia, liver injury, and GI side effects

429. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
     March 01, 2011 - Liver injury 3. Congestive heart failure 4. Severe lactic acidosis 5. Cancer 6. … We also found little evidence regarding liver injury and cancer, outcomes included in the 2007 evidence … Liver injury High The risk of liver injury was similar for thiazolidinediones and sulfonylureas. … Moderate The rates of liver injury were similar between thiazolidinediones and metformin. 15 Table

430. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
     September 01, 2009 - Levels of cholesterol are influenced by its production in the liver and the ingestion of dietary fats … Known as statins, these agents reduce the production of cholesterol in the liver by binding with the … significant differences between treatments for the outcomes of withdrawal due to adverse events and liver … In general, studies excluded participants with statin-associated myopathy, deranged liver enzymes, high … prerandomization run-in phase to minimize nonadherence, and conducted frequent laboratory monitoring for liver

431. Failure to Reevaluate | PSNet
     psnet.ahrq.gov/web-mm/failure-reevaluate
     February 01, 2014 - , gender, weight, muscle metabolism, and protein intake.( 4 ) Specifically, patients with end-stage liver … Scr may not reflect renal function in patients with reduced muscle mass, malnutrition, and end-stage liver

432. Clinical Classifications for Health Policy Research: Hospital Inpatient Statistics, 1995
     hcup-us.ahrq.gov/reports/natstats/his95/appca.htm
     February 11, 2011 - 2.2.2 Cancer of stomach 13 - 2.2.3 Cancer of liver … Secondary malignancy of lung - 1970 2.12.3 Secondary malignancy of liver

433. Spotlight Case July 2008 (ppt file)
     psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.182_slideshow.ppt
     September 01, 2008 - Liver and spleen were palpable, the latter extending 6 cm below the left costal margin. … Case C: Part 1—Other Test Results Test Result BUN 56 mg/dL Bilirubin 4.2 mg/dL AST/GGT (liver

434. Comorbidity Software (pdf file)
     hcup-us.ahrq.gov/reports/methods/ComorbiditySoftwareDocumentationFinal.pdf
     September 30, 2004 - Liver disease ICD-9-CM codes: 070.22, 070.23, 070.32, 070.33, 070.44, 070.54, 456.0, 456.1, 456.20 … 571.40-571.49, 571.5, 571.6, 571.8, 571.9, 572.3, 572.8, V42.7 Discharge does not have these DRGs: Liver

435. Section5 8 (pdf file)
     hcup-us.ahrq.gov/reports/factsandfigures/2008/pdfs/section5_8.pdf
     January 01, 2008 - conditions that accompanied a secondary SA diagnosis in 2008 included conditions affecting the pancreas, liver

436. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/33604/psn-pdf
     December 15, 2024 - light of patient condition, medication list, age, weight, ethnicity, diet, allergies, and kidney and liver

437. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49872/psn-pdf
     August 08, 2019 - cell count of greater than 30,000 (normal range 4,000–11,000) and was found to be in acute renal and liver … failure with a creatinine of 3.6 mg/dL (normal range 0.4–1.0 mg/dL) and markedly elevated liver function

438. Comparative Effectiveness of Antiviral Treatment for Hepatitis C Virus Infection in Adults: A Systematic Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/o6pGCffkVCx24mNebJGCXg
     January 01, 2013 - , in- cluding cirrhosis, liver failure, hepatocellular carcinoma, and death (1, 2). … Ghany MG, Strader DB, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. … Strader DB, Wright T, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. … Liver Int. 2011;31:401-11. [PMID: 21281434] 26. Khan A, Awan A, Shahbuddin S, Iqbal Q. … J Gastrointestin Liver Dis. 2006;15:213-9. [PMID: 17013444] 55.

439. Neds 2017 Ip Maskedstats (pdf file)
     hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2017_IP_MaskedStats.PDF
     January 01, 2017 - MAJ O.R. 8,098 0.17 4: TRACH W MV >96 HRS OR PDX EXC FACE, MOUTH & NECK W/O MAJ O.R. 6,877 0.15 5: LIVER … TRANSPLANT W MCC OR INTESTINAL TRANSPLANT 170 0.00 6: LIVER TRANSPLANT W/O MCC 16 0.00 7: LUNG TRANSPLANT … , LIVER & SHUNT PROCEDURES W/O CC/MCC 89 0.00 408: BILIARY TRACT PROC EXCEPT ONLY CHOLECYST W OR W/O … EXCEPT MALIG,CIRR,ALC HEPA W MCC 9,982 0.21 442: DISORDERS OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W CC … 11,769 0.25 443: DISORDERS OF LIVER EXCEPT MALIG,CIRR,ALC HEPA W/O CC/MCC 3,238 0.07 444: DISORDERS

440. 2012 HCUP National Inpatient Sample (NIS) Comparison Report
     hcup-us.ahrq.gov/db/nation/nis/reports/2012niscomparisonrpt.jsp
     April 18, 2016 - Trach w mv 96+ hrs or pdx exc face, mouth & neck w/o maj O.R. 26,996 24,250 -10.2 5 Liver … transplant w mcc or intestinal transplant 1,268 1,120 -11.7 6 Liver transplant w/o mcc … & shunt procedures w mcc 5,854 5,890 0.6 406 Pancreas, liver & shunt procedures w … cc 7,060 6,710 -5.0 407 Pancreas, liver & shunt procedures w/o cc/mcc 2,788 2,605 … ,cirr,alc hepa w cc 27,949 26,865 -3.9 443 Disorders of liver except malig,cirr,alc hepa